0 Valutazioni
ID

26065

Descrizione

Exclusion Criteria second visit Ropinirole Case Report Form Concomitant Medication Ropinirole Case Report Form GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Keywords

versioni (1)
  1. 05/10/17 05/10/17 -
Titolare del copyright

gsk

Caricato su

5 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Exclusion Criteria second visit Ropinirole Case Report Form GSK RRL100013

    Inglese

    Exclusion Criteria second visit Ropinirole Case Report Form GSK RRL100013

    1 moduli  
    Administrative documentation
    Descrizione

    Administrative documentation

    Alias
    UMLS CUI-1
    C1320722 (Administrative documentation)
    SNOMED
    405624007
    Study No
    Descrizione

    Study No

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C2826693 (Study Identifier)
    Subject No.:
    Descrizione

    Subject No.

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Panel ID:
    Descrizione

    Group identity

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C3826248 (Group identity)
    Visit:
    Descrizione

    Visit

    Tipo di dati

    integer

    Alias
    UMLS CUI [1]
    C1549755 (Visit Number)
    Date
    Descrizione

    DD/MON/YY

    Tipo di dati

    date

    Alias
    UMLS CUI [1]
    C0011008 (Date in time)
    SNOMED
    410671006
    Exclusion Criteria
    Descrizione

    Exclusion Criteria

    Alias
    UMLS CUI-1
    C0680251 (Exclusion Criteria)
    7. Does the subject have an abuse of alcohol, defined as an average weekly intake of greater than 21 units or an average daily intake greater than 3 units for men; greater than 14 units per week or greater than 2 units per day for women?
    Descrizione

    One unit is equivalent to half a pint of beer, one measure of spirits or one glass of wine.

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0038586 (Substance Use Disorders)
    8. Has the subject participated in another clinical trial, blood donation or has the subject lost blood less than 90 days before the present study?
    Descrizione

    Other clinical trial, blood donation or blood loss

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0679823 (Participation)
    UMLS CUI [1,2]
    C1516648 (Clinical Trial, Other)
    UMLS CUI [2]
    C0005794 (Blood Donation)
    UMLS CUI [3]
    C3163616 (Blood Loss)
    9. Does the subject have a positive pre-study screening result for hepatitis B surface antigen, hepatitis C antibody or HIV-1/2 antibodies?
    Descrizione

    Hepatitis B, C or HIV antibodies

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C2711110 (Hepatitis B and hepatitis C)
    SNOMED
    442374005
    UMLS CUI [2]
    C0019683 (HIV Antibodies)
    SNOMED
    259855002
    10. Is the subject pregnant and/or breast-feeding?
    Descrizione

    Pregnant or breast-feeding

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0549206 (Patient currently pregnant)
    SNOMED
    77386006
    LOINC
    LA14670-6
    UMLS CUI [2]
    C0006147 (Breast Feeding)
    SNOMED
    169741004
    LOINC
    LP420040-0
    11. Is the subject a female of child-bearing potential who is not practising a clinically accepted method of contraception such as surgical sterilisation, 1.U.D., diaphragm in conjunction with spermicidal foam and condom on the male partner, or systemic contraception (i.e., Norplant)?
    Descrizione

    No contraception

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C3831118 (Childbearing Potential)
    UMLS CUI [1,2]
    C0445107 (Not used)
    SNOMED
    262009000
    LOINC
    LA157-0
    UMLS CUI [1,3]
    C0700589 (Contraceptive methods)
    SNOMED
    13197004
    12. Is the subject a female with positive urine/serum pregnancy test result at screening?
    Descrizione

    Positive pregnancy test

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0240802 (Pregnancy test positive)
    SNOMED
    250423000
    Ritorna all'inizio della pagina

    Similar models

    Exclusion Criteria second visit Ropinirole Case Report Form GSK RRL100013

    1 moduli
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Administrative documentation
    C1320722 (UMLS CUI-1)
    Study No
    Item
    Study No
    integer
    C2826693 (UMLS CUI [1])
    Subject No.
    Item
    Subject No.:
    integer
    C2348585 (UMLS CUI [1])
    Group identity
    Item
    Panel ID:
    integer
    C3826248 (UMLS CUI [1])
    Visit
    Item
    Visit:
    integer
    C1549755 (UMLS CUI [1])
    Date
    Item
    Date
    date
    C0011008 (UMLS CUI [1])
    Item Group
    Exclusion Criteria
    C0680251 (UMLS CUI-1)
    Alcohol abuse
    Item
    7. Does the subject have an abuse of alcohol, defined as an average weekly intake of greater than 21 units or an average daily intake greater than 3 units for men; greater than 14 units per week or greater than 2 units per day for women?
    boolean
    C0038586 (UMLS CUI [1])
    Other clinical trial, blood donation or blood loss
    Item
    8. Has the subject participated in another clinical trial, blood donation or has the subject lost blood less than 90 days before the present study?
    boolean
    C0679823 (UMLS CUI [1,1])
    C1516648 (UMLS CUI [1,2])
    C0005794 (UMLS CUI [2])
    C3163616 (UMLS CUI [3])
    Hepatitis B, C or HIV antibodies
    Item
    9. Does the subject have a positive pre-study screening result for hepatitis B surface antigen, hepatitis C antibody or HIV-1/2 antibodies?
    boolean
    C2711110 (UMLS CUI [1])
    C0019683 (UMLS CUI [2])
    Pregnant or breast-feeding
    Item
    10. Is the subject pregnant and/or breast-feeding?
    boolean
    C0549206 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    No contraception
    Item
    11. Is the subject a female of child-bearing potential who is not practising a clinically accepted method of contraception such as surgical sterilisation, 1.U.D., diaphragm in conjunction with spermicidal foam and condom on the male partner, or systemic contraception (i.e., Norplant)?
    boolean
    C3831118 (UMLS CUI [1,1])
    C0445107 (UMLS CUI [1,2])
    C0700589 (UMLS CUI [1,3])
    Positive pregnancy test
    Item
    12. Is the subject a female with positive urine/serum pregnancy test result at screening?
    boolean
    C0240802 (UMLS CUI [1])
    Ritorna all'inizio della pagina 

    Aiuto

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial